- Home
- BHAT vs ADXN Comparison
BHAT vs ADXN Comparison
Compare BHAT & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHAT
- ADXN
- Stock Information
- Founded
- BHAT 2010
- ADXN 2002
- Country
- BHAT China
- ADXN Switzerland
- Employees
- BHAT N/A
- ADXN N/A
- Industry
- BHAT Recreational Games/Products/Toys
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- BHAT Consumer Discretionary
- ADXN Health Care
- Exchange
- BHAT Nasdaq
- ADXN Nasdaq
- Market Cap
- BHAT 59.1M
- ADXN 8.5M
- IPO Year
- BHAT 2019
- ADXN N/A
- Fundamental
- Price
- BHAT $1.50
- ADXN $8.85
- Analyst Decision
- BHAT
- ADXN
- Analyst Count
- BHAT 0
- ADXN 0
- Target Price
- BHAT N/A
- ADXN N/A
- AVG Volume (30 Days)
- BHAT 103.6K
- ADXN 24.6K
- Earning Date
- BHAT 12-22-2025
- ADXN 11-21-2025
- Dividend Yield
- BHAT N/A
- ADXN N/A
- EPS Growth
- BHAT N/A
- ADXN N/A
- EPS
- BHAT N/A
- ADXN N/A
- Revenue
- BHAT $18,724,190.00
- ADXN $210,347.00
- Revenue This Year
- BHAT N/A
- ADXN $86.57
- Revenue Next Year
- BHAT N/A
- ADXN N/A
- P/E Ratio
- BHAT N/A
- ADXN N/A
- Revenue Growth
- BHAT N/A
- ADXN N/A
- 52 Week Low
- BHAT $1.34
- ADXN $6.51
- 52 Week High
- BHAT $27.59
- ADXN $12.05
- Technical
- Relative Strength Index (RSI)
- BHAT 33.63
- ADXN 47.30
- Support Level
- BHAT $1.34
- ADXN $8.60
- Resistance Level
- BHAT $1.58
- ADXN $9.79
- Average True Range (ATR)
- BHAT 0.08
- ADXN 0.84
- MACD
- BHAT -0.01
- ADXN -0.09
- Stochastic Oscillator
- BHAT 43.03
- ADXN 9.31
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.